Dr. Wai-Kay Seto’s team: Multiple Studies on Hepatic Diseases Management with New Hepatitis B Drugs, Fatty Liver Monitoring, and Liver Cancer Risk Factors
The 58th Annual Meeting of the European Association for the Study of the Liver (EASL2023) and the EASL Congress 2023 have come to a close. During this conference, Dr. Wai-Kay…
